Public Company News

Forrester: Customer Trust In Financial Services Providers Is Weak Across Most Of Asia Pacific

Customers seek greater empathy, dependability, and competence from their banks, investment firms, and life insurers SINGAPORE, May 17, 2023 /PRNewswire/ --  According to Forrester's (Nasdaq: FORR) Financial Services Customer Trust Index

2023-05-17 09:30 4321

Antengene Announces NDA Submission for XPOVIO® in Indonesia

SHANGHAI and HONG KONG, May 17, 2023 /PRNewswire/ -- Antengene Corporation Limited ("Antengene" SEHK: 6996.HK), a leading innovative, commercial-stage global biopharmaceutical company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class therapeutics in hema...

2023-05-17 08:30 4113

Transcenta Announces Encouraging Phase I Clinical Data of TST002 (Blosozumab) in Chinese Patients with Reduced Bone Mineral Density

SUZHOU, China, May 17, 2023 /PRNewswire/ -- Transcenta Holding Limited ("Transcenta") (HKEX: 06628), a clinical stage biopharmaceutical company with fully-integrated capabilities in discovery, research, development and manufacturing of antibody-based therapeutics,announces encouraging phase I cl...

2023-05-17 08:17 3855

Innovent Announces Clinical Data of Multiple Trials Will be Presented at the 2023 ASCO and EHA Annual Meetings

ROCKVILLE, Md. and SUZHOU, China, May 17, 2023 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, autoimmune, metabolic, ophthalmology and...

2023-05-17 08:00 6261

Everest Medicines Announces Completion of Patient Enrollment in Phase 3 Clinical Trial of Etrasimod in Asia

SHANGHAI, May 17, 2023 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the development, manufacturing and commercialization of innovative medicines and vaccines, announced today the completion of patient enrollment in a multi-...

2023-05-17 07:48 5733

Hollysys Automation Technologies Reports Unaudited Financial Results for the Third Quarter and the First Nine Months Ended March 31, 2023

First Nine Months of Fiscal Year 2023 Financial Highlights * Total revenues were $582.4 million, an increase of 10.9% compared to the comparable prior year period. * Gross margin was 33.4%, compared to 33.9% for the comparable prior year period.Non-GAAP gross margin was 33.6%, compared to 34....

2023-05-17 05:00 3941

Fresh2 Files Annual Report on Form 20-F for Fiscal Year 2022

NEW YORK, May 16, 2023 /PRNewswire/ -- Fresh2 Group Limited (Formerly AnPac Bio-Medical Science Co., Ltd., "Fresh2," the "Company" or "we") (NASDAQ: ANPC), a company with operations inthe United States and China focused on early cancer screening and detection and entering into the operation of a ...

2023-05-17 05:00 4233

Emeren Group to File 2022 Annual Report 20F

STAMFORD, CT, May 16, 2023 /PRNewswire/ -- Emeren Group Ltd ("Emeren" or the "Company") (www.emeren.com ) (NYSE: SOL), a leading global solar project developer, owner, and operator, today announced that it will restate its previously issued unaudited consolidated financial ...

2023-05-17 04:34 4002

Waters Corporation Completes Acquisition of Light Scattering Leader Wyatt Technology

MILFORD, Mass., May 17, 2023 /PRNewswire/ -- Waters™ Corporation (NYSE: WAT) today announced it has completed its acquisition of Wyatt Technology, a pioneer and well-recognized leader in innovative light scattering and field-flow fractionation instruments, software, accessories, and services. Wi...

2023-05-17 04:15 8316

Fresh2 Reports First Quarter of Fiscal Year 2023 Financial Results

NEW YORK, May 16, 2023 /PRNewswire/ -- Fresh2 Group Limited (Formerly AnPac Bio-Medical Science Co., Ltd., "Fresh2," the "Company" or "we") (NASDAQ: ANPC), a company with operations inthe United States and China focused on early cancer screening and detection and entering into the operation of a ...

2023-05-17 04:15 3374

Fresh2 Reports Fiscal Year 2022 Annual Financial Results

NEW YORK, May 16, 2023 /PRNewswire/ -- Fresh2 Group Limited (Formerly AnPac Bio-Medical Science Co., Ltd. ,"Fresh2," the "Company" or "we") (NASDAQ: ANPC), a company with operations inthe United States and China focused on early cancer screening and detection and entering into the operation of a ...

2023-05-17 04:15 3306

Absolut, the World's First Vodka Brand to Create Visual Cocktail Art Using AI, Invites You to 'Mix Your Neighbourhood'

The first-of-its-kind cocktails are uniquely inspired by the people, places, and cultures that define neighbourhoods acrossCanada TORONTO, May 17, 2023 /PRNewswire/ -- Absolut Vodka has always believed that you can push creative boundaries and proudly boasts a progressive mindset in culture. So,...

2023-05-17 04:00 3080

Boan Biotech's BA1202 Approved for Clinical Trial

-The First Novel CEA/CD3 Bispecific Antibody in China- YANTAI, China, May 16, 2023 /PRNewswire/ -- Boan Biotech announced today that its BA1202, a CEACAM5 (CEA)/CD3 bispecific antibody, has been approved for a clinical trial by the Center for Drug Evaluation ofChina's National Medical Products A...

2023-05-16 22:02 8127

LTIMindtree Launches A Comprehensive Suite Of Assurance & Compliance Services Platform, Rely, For S/4HANA Programs In Collaboration With Tricentis

EDISON, N.J. and MUMBAI, India, May 16, 2023 /PRNewswire/ -- LTIMindtree (NSE: LTIM) (BSE: 540005), a global technology consulting and digital solutions company, in collaboration with Tricentis, a global leader in enterprise continuous testing and quality engineering...

2023-05-16 21:39 4281

DxVx appoints Yong Gu Lee as new CEO and Kevin Kwon as the new president

- Reorganizing the global sales networks and enhancing its capabilities to get global approvals for new drug - Accelerating value of the new drug pipelines SEOUL, South Korea, May 16, 2023 /PRNewswire/ -- DxVx announced on the 16th, the board of directors appointedYong Gu Lee as the new CEO and ...

2023-05-16 21:00 4351

Amorepacific Holds the Skin Epigenetics Symposium at the International Societies for Investigative Dermatology 2023

SEOUL, South Korea, May 16, 2023 /PRNewswire/ -- Amorepacific held the "Skin Epigenetics – Sulwhasoo Symposium" at International Societies for Investigative Dermatology Meeting 2023 (ISID 2023) inTokyo, Japan. During the symposium on May 11 (Thursday), under the theme of skin epigenetics, Amorepa...

2023-05-16 21:00 3185

Artmarket.com: A solid but still uncrowned Art Market in 2023. Artprice reviews Christie's first spring results in New York

PARIS, May 16, 2023 /PRNewswire/ -- With no 'absolute masterpieces' on offer, there were no 'mega' results in Christie's first major prestigeNew York sale of 2023. Lots of works fetched over$10 million on May 11, but none crossed the threshold of$50 million. Indeed last year's peak at the same sa...

2023-05-16 20:37 4461

Tantech Exports Midibus to Dominica

LISHUI, China, May 16, 2023 /PRNewswire/ -- Tantech Holdings Ltd (NASDAQ: TANH) ("Tantech" or the "Company") today announced that its subsidiary, Shangchi Automobile Co., Ltd., has recently signed a new contract to export electric midibus toDominica. Measuring 6 meters long and close to 2 meters...

2023-05-16 20:30 4012

Farmmi Shipping High-Volume Mushroom Order to Canada

LISHUI, China, May 16, 2023 /PRNewswire/ -- Farmmi, Inc. ("Farmmi" or the "Company") (NASDAQ: FAMI), an agriculture products supplier inChina, today announced it is shipping a new high-volume mushroom order for its commercialized black fungus to export toCanada. Ms. Yefang Zhang, Farmmi's Chai...

2023-05-16 20:30 3666

Symbio's South-East Asia Hub unlocks multi-country access with one interconnect

SYDNEY, May 16, 2023 /PRNewswire/ -- Symbio Holdings Limited (ASX: SYM), a leading voice communications software provider, today announced the launch of itsSouth-East Asia (SEA) Regional Hub. Launching across Singapore and Malaysia initially, Symbio's SEA Regional Hub will provide cost efficient,...

2023-05-16 20:00 3874